Nectar Lifesciences Limited (NSE:NECLIFE)
India · Delayed Price · Currency is INR 12.09
-0.36 (-2.89%)
Jun 1, 2026, 3:28 PM IST
Nectar Lifesciences Market Cap
Nectar Lifesciences has a market cap or net worth of 2.35 billion as of June 1, 2026. Its market cap has decreased by -53.25% in one year.
Market Cap
2.35B
Enterprise Value
1.10B
Revenue
92.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.09
Market Cap Chart
Since July 18, 2005, Nectar Lifesciences's market cap has decreased from 2.87B to 2.35B, a decrease of -18.04%. That is a compound annual growth rate of -0.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 2.35B | -46.04% |
| Dec 31, 2025 | 4.35B | -50.21% |
| Dec 31, 2024 | 8.74B | 21.24% |
| Dec 29, 2023 | 7.21B | 30.96% |
| Dec 30, 2022 | 5.51B | -8.40% |
| Dec 31, 2021 | 6.01B | 12.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jagsonpal Pharmaceuticals | 13.87B |
| Ind-Swift Laboratories | 13.19B |
| Sigachi Industries | 8.14B |
| Valiant Laboratories | 4.21B |
| Bafna Pharmaceuticals | 3.12B |
| Brooks Laboratories | 1.92B |
| Alpa Laboratories | 1.50B |
| Balaxi Pharmaceuticals | 1.45B |